TANFANERCEPT
UNII Z39Q6AB0ZR

Substance Identification & Data

This profile provides standardized clinical and technical data for Tanfanercept, uniquely identified by the FDA Unique Ingredient Identifier (UNII) Z39Q6AB0ZR.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2119738-70-2 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

Z39Q6AB0ZR

CAS Registry Number

2119738-70-2

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

TANFANERCEPT

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C170384

National Cancer Institute reference terminology for clinical and research data.

INN ID

10923

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

HI-133

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tanfanercept. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TANFANERCEPT

Common Names & Synonyms

41-211-TUMOR NECROSIS FACTOR RECEPTOR 1

TANFANERCEPT [INN]

TANFANERCEPT [USAN]

TANFANERCEPT [WHO-DD]

Systematic Nomenclature

L-METHIONYL-(L28>V,S52>M,H55>F,R57>P,H58>G,K121>N) TUMOR NECROSIS FACTOR (TNF) BINDING PROTEIN VARIANT 1 (TBP-1) WITH C-TERMINAL EXTENSION BY FURTHER 10 RESIDUES OF THE PRO-PROTEIN, HUMAN, UNGLYCOSYLATED

SYS